JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

Bromodomain

B5998 GSK2801

Summary: inhibitor of BAZ2A and BAZ2B bromodomains

insoluble in H2O; ≥18.55 mg/mL
B5973 PFI 4

Summary: Potent and selective BRPF1 Bromodomain inhibitor

insoluble in H2O; ≥13.3 mg/mL
B5670 I-BET 151 hydrochloride
1 Citation

Summary: BET bromodomain inhibitor
B4918 OXF BD 02

Summary: Selective inhibitor of the first bromodomain of BRD4

<29.53 mg/mL
B4917 Ischemin sodium salt

Summary: CBP bromodomain inhibitor

<35.74 mg/mL
B4916 GSK 5959

Summary: BRPF1 bromodomain inhibitor

≥39.4 mg/mL
B4915 BAZ2-ICR

Summary: Selective BAZ2 bromodomain inhibitor

<35.74 mg/mL
B4895 OF-1

Summary: BRPF1B and BRPF2 bromodomain inhibitor

insoluble in H2O; insoluble in EtOH; ≥14.55 mg/mL
B1500 I-BET151 (GSK1210151A)
2 Citation

Target: Bromodomain and Extra-Terminal motif (BET)

Summary: Selective BET inhibitor

≥41.5 mg/mL
B1499 RVX-208
2 Citation

Summary: Potent BET bromodomain inhibitor

insoluble in H2O; ≥18.52 mg/mL